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Abstract
Background:  Disseminated mycobacterial disease is an important cause of morbidity and
mortality in patients with HIV-infection. Nonspecific clinical presentation makes the diagnosis
difficult and sometimes neglected.
Methods:  We conducted a retrospective cohort study to compare the presentation of
disseminated Mycobacterial tuberculosis (MTB) and non-tuberculous Mycobacterial (NTM) disease in
HIV-positive patients from 1996 to 2006 in Brazil.
Results: Tuberculosis (TB) was diagnosed in 65 patients (67.7%) and NTM in 31 (32.3%) patients.
Patients with NTM had lower CD4 T cells counts (median 13.0 cells/mm3 versus 42.0 cells/mm3, P
= 0.002). Patients with tuberculosis had significantly more positive acid-fast smears (48.0% vs 13.6%,
P = 0.01). On chest X-ray, miliary infiltrate was only seen in patients with MTB (28.1% vs. 0.0%, P
= 0.01). Pleural effusion was more common in patients with MTB (45.6% vs. 13.0%, P = 0.01).
Abdominal adenopathy (73.1% vs. 33.3%, P = 0.003) and splenic hypoechoic nodules (38.5% vs. 0.0%,
P = 0.002) were more common in patients with TB.
Conclusion: Miliary pulmonary pattern on X-ray, pleural effusion, abdominal adenopathy, and
splenic hypoechoic nodules were imaging findings associated with the diagnosis of tuberculosis in
HIV-infected patients. Recognition of these imaging features will help to distinguish TB from NTM
in AIDS patients with fever of unknown origin due to disseminated mycobacterial disease.
Background
The use of highly active antiretroviral (HAART) therapy
has been associated with a marked decrease in the inci-
dence of opportunistic disease in patients with AIDS [1,2].
The incidence of non-tuberculous mycobacteria especially
Mycobacterium avium complex (MAC) infections, the most
common mycobacterial disease among immune compro-
mised patients in developed countries [3,4], has dramati-
cally declined since 1995 because of HAART [1,5]. For
Mycobacterial tuberculosis (MTB) infections, this reduction
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was not so dramatic [6], but observational studies have
demonstrated a protective effect of HAART in patients
infected with MTB [7,8].
Universal access to antiretroviral medications has reduced
the risk of tuberculosis in patients with AIDS in develop-
ing countries such as Brazil [9,10]. However, infections
with MTB have reached endemic levels and continue to be
a major public health problem in these countries [11,12].
Although previous mycobacterial infection has been asso-
ciated with protection against subsequent mycobacterial
infection [13], this is not always the rule [14]. On the
other hand, the diagnosis of non-tuberculous mycobacterial
(NTM) disease is still neglected in these settings consider-
ing its variable prevalence [3,4,13,15]. In Brazil, the rate of
NTM disease can vary from 0% to 45% [11,16-18]. Myco-
bacterium avium complex is the major NTM specie identi-
fied in Brazil [19].
Rapid laboratorial detection of Mycobacterial species is dif-
ficult due to its dependence on the growth of usually slow
growing mycobacteria. Speciation of a Mycobacterium iso-
late using these standard methods is a lengthy process
based on subjective data interpretation. Commercially
available molecular methods for speciation represent a
useful and promising tool but are expensive and do not
cover the number of mycobacteria that can be reliably
identified in clinical laboratories. In addition, diagnosis
based solely on the clinical presentation is unreliable con-
sidering that most HIV-infected patients with dissemi-
nated disease present systemic symptoms, such as fever,
weight loss, and anorexia [20,21].
Abdominal and chest imaging are the initial steps in the
investigation of fever of unknown origin (FUO) [22].
Considering that mycobacterial infections are the most
common cause of FUO in patients with AIDS [23,24],
radiological manifestations might be an important clue
for the early diagnosis of tuberculosis (TB) or NTM disease
in HIV-infected patients.
The goal of our study was to determine the most common
radiological findings in patients with AIDS and dissemi-
nated mycobacterial disease caused by NTM and MTB in a
tertiary care-hospital in Brazil.
Methods
We performed a retrospective cohort study at Hospital de
Clínicas de Porto Alegre, a 735-bed accommodation terti-
ary-care hospital located in southern Brazil. From 1996 to
2006 all patients with the diagnosis of HIV infection and
disseminated mycobacterial disease were included in the
study. Patients were selected by the review of data from
the records of microbiology laboratory.
Disseminated disease was characterized when we had a
positive identification of MTB or NTM in either one of the
following cultures: blood, bone marrow, or liver biopsies.
For isolation of Mycobacterium  sp. a radiometric system
(BACTEC 460 TB – Becton & Dickinson Diagnostic Instru-
ment Systems, Sparks, MD, USA), and non-radiometric sys-
tems (BACTEC 9240 – Becton & Dickinson Diagnostic
Instrument Systems, Sparks, MD, USA; and, BacT/Alert 240
– bioMérieux, Marcy-lEtoile, France) were used. For identi-
fication of MTB or NTM, NAP (p-nitro-alfa-acetylamino-beta-
hydroxypropiophenone) test was performed [25,26]. This test
is highly specific for the identification of Mycobacterium
tuberculosis complex (99%) [27]. In cases which NAP test
could not be done, the identification of species were made
by the visualization of the aspect of the colony – presence
or absence of cord formation in liquid media – due to the
high sensitivity and specificity of this method [28,29]. We
did not use DNA probes for speciation of mycobacteria.
We included for analysis, the most recent CD4 lym-
phocyte count and HIV viral load test in a six-month
period before the hospital arrival.
The imaging studies included – chest X-ray, abdominal
ultrasound or computerized tomography (CT) – referred
only to exams performed during the first 21 days of the
patient's hospital stay.
A descriptive analysis of all the variables collected from
each patient was performed. The chi-squared test or
Ficher's exact test was used for univariate analysis of
selected variables. Associations were considered statisti-
cally significant when P value was < 0.05. Data were com-
piled using Epi-Info 6.04 version and analyzed in SPSS
11.5 version program.
The ethic committee of Hospital de Clínicas de Porto Ale-
gre approved the study. The authors signed a written com-
mitment to guarantee the confidentiality of the data
retrospectively collected.
Results
One-hundred and seven patients with disseminated
mycobacterial disease were identified from 1996 to 2006.
Eleven patients were excluded from the comparative anal-
ysis: six (5.6%) for incomplete data registry, three (2.8%)
for simultaneous diagnosis of TB and NTM disease, and
two (1.9%) because of lack of species identification. From
the 96 remaining patients, disseminated TB was diag-
nosed in sixty-five patients (67.7%), and thirty-one
(32.3%) had NTM disease.
The characteristics of patients with TB and NTM are
shown in Table 1. A lower CD4 lymphocyte count wasBMC Infectious Diseases 2008, 8:24 http://www.biomedcentral.com/1471-2334/8/24
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associated with NTM infection. Black race was associated
with the diagnosis of TB. Patients with NTM were more
exposed or were on use of HAART than patients with TB
(57.6% versus 25.8%; P = 0.004). There was no significant
difference between TB group and NTM group with respect
to any other parameter. None of the patients were on
MAC chemoprophylaxis. And none of the patients had
the diagnosis of IRIS (immune reconstitution inflamma-
tory syndrome).
Our study confirms the high sensitivity and specificity of
the presence of cord formation [28,29]. Considering the
culture as the gold standard, sixty-four of 65 patients with
TB had the presence of cord formation (sensitivity of
98%) and 30 of 31 patients with NTM disease had non-
cord formation (specificity of 96%) by the visualization of
the aspect of the colony.
There was no statistical significant difference comparing
the clinical presentation in both groups of patients. The
most common clinical symptoms were as follows: weight
loss (92.7%), fever (89.6%), respiratory symptoms
(75.0%), such as cough, hemoptysis, shortness of breath,
and chest pain, and gastrointestinal manifestations
(68.8%).
Only 27 patients had positive results on acid-fast smear
on sputum or bronchoalveolar lavage, of these, twenty-
four (48.0%) in the TB group and three (13.6%) in NTM
infection group (P = 0.01).
The chest films and abdominal ultrasound or CT findings
are shown in Table 2 and 3, respectively. The chest X-ray
was normal in ten (13.2%) patients, while in abdominal
image the result was normal in five (7.7%). There was no
Table 1: Demographic characteristics of the HIV-infected patients with disseminated Mycobacterial disease
All Patients1 (n = 96) MTB (n = 65) NTM (n = 31) P
Age 32.0 32.0 34.0 .43
Men 71 (74.0) 49 (75.4) 22 (71.0) .83
Race2 .05
White 63 (66.3) 39 (60.9) 24 (77.4)
Black 23 (24.2) 20 (31.3) 3 (9.7)
Other 9 (9.5) 5 (7.8) 4 (12.9)
HIV exposure .34
Sexual 46 (57.5) 28 (52.8) 18 (56.7)
IV drug use 34 (42.5) 25 (47.2) 9 (33.3)
Previous ART 35 (36.4) 17 (25.8) 18 (57.6) .004
Median CD4 (cels/mm3) 
(No. of patients)
(53) 42.0 (34) 13.0 (19) .002
Median viral load (log/mL) 
(No. of patients)
5.2 (11) 4.7 (5) 5.4 (6) .83
Anti-HCV positive 26 (35.6) 18 (37.5) 8 (32.0) .83
HBsAg positive 6 (8.8) 4 (8.5) 2 (9.5) .74
Note. Data are no. (%) of patients, unless otherwise indicated. MTB, Mycobacterium tuberculosis; NTM, non-tuberculous mycobacteria; IV, intravenous; 
ART, antiretroviral therapy.
1 Patients diagnosed with tuberculosis and non-tuberculous mycobacteria infection.
2 P value related to black and white race groups comparison.
Table 2: Chest X-ray abnormalities in HIV-infected patients with disseminated mycobacterial disease
All Patients1 (n = 80) MTB (n = 57) NTM (n = 23) P
Diffuse infiltrate 41 (51.3) 28 (49.1) 13 (56.5) .72
Consolidation 30 (37.5) 21 (36.8) 9 (39.1) .92
Pleural effusion 29 (36.3) 26 (45.6) 3 (13.0) .001
Adenopathy 25 (31.3) 21 (36.8) 4 (17.4) .15
Miliary infiltrate 16 (20.0) 16 (28.1) 0 (0.0) .001
Atelectasis 3 (3.8) 2 (3.5) 1 (4.3) .63
Cardiomegaly 3 (3.8) 2 (3.5) 1 (4.3) .63
Cavitation 3 (3.8) 3 (5.3) 0 (0.0) .63
Nodules 3 (3.8) 3 (5.3) 0 (0.0) .63
Note. Data are no. (%) of patients, unless otherwise indicated. MTB, Mycobacterium tuberculosis; NTM, non-tuberculous mycobacteria.
1 Patients diagnosed with tuberculosis, and non-tuberculous mycobacteria infection.BMC Infectious Diseases 2008, 8:24 http://www.biomedcentral.com/1471-2334/8/24
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difference in terms of presence or absence of positive find-
ings on chest X-ray or abdominal imaging comparing the
patients with MTB or NTM disease. Seven patients
(24.0%) with NTM infection and five (8.0%) patients
with tuberculosis had normal chest X-ray findings (P =
0.07). One patient (4.5%) with NTM and three patients
(5.5%) with MTB infection had normal abdominal find-
ings on ultrasound or CT (P = 0.68).
The most common findings on chest X-ray of HIV-
infected patients with disseminated mycobacterial disease
were pulmonary interstitial infiltrate (51.3%), consolida-
tion (37.5%), pleural effusion (36.3%), and adenopathy
(31.3%). On abdominal image, adenopathy (61.6%),
hepatomegaly (41.1%), ascites (34.2%), and splenic
hypodense lesions (27.4%) were the most common
abnormalities described. Micronodular infiltrate was
identified in sixteen patients (28.1%) with MTB infection
and in none with NTM disease (P = 0.01). Pleural effusion
was more common in patients with TB (45.6% vs 13.0%.
P = 0.01). Other chest X-ray abnormalities were similar in
both groups. Abdominal adenopathy was more frequent
in patients with disseminated TB (73.1%, n = 38) than
patients with NTM disease (33.3%, n = 7; P = 0.003). Only
patients with MTB infection presented splenic hypodense
lesions (38.5%; n = 20; P = 0.002). Other abdominal find-
ings were associated with neither TB nor NTM infection.
When patients were stratified for the lowest CD4 lym-
phocyte count strata (CD4 ≤ 50 cels/mm3), all the imag-
ing abnormalities previously associated to the diagnosis
of disseminated TB (miliary infiltrate, pleural effusion,
abdominal adenopathy, and splenic hypodense nodules)
remained statistically significant for this diagnosis.
Discussion
We identified relevant imaging features that could help to
distinguish TB from NTM in patients with AIDS and dis-
seminated mycobacterial disease. The presence splenic
hypoechoic nodules or micronodules suggestive of
splenic microabscesses on abdominal ultrasound and CT
scan were highly specific for TB in HIV-patients with dis-
seminated mycobacterial disease, considering it was not
seen in patients with NTM infection. Studies have demon-
strated a higher prevalence of splenic lesions in HIV-
infected patients with disseminated TB compared with
those with disseminated NTM [30,31]. Bernabeu-Wittel et
al have shown, in 36 patients with HIV infection and
splenic microabscesses, that TB and NTM were the aetiol-
ogy of 43% and 15% of patients respectively [30]. Radin
found that 30% of patients with tuberculosis and 7% of
patients with MAC had focal lesions in the spleen [31].
Previous non-comparative studies [32,33] have shown the
association between TB and abdominal adenopathy.
Monill-Serra, for instance, found that out of 76 patients
with TB, twenty-seven had the presence of retroperitoneal
and mesenteric adenopathy on sonographic imaging.
Although some authors have advocated that virtually
100% of HIV-infected patients with MAC presented
abdominal adenopathy [31,34,35], in our population the
presence of adenopathy were predominantly seen in HIV-
infected patients with TB.
Considering intrathoracic adenopathy, Jasmer et al [36]
evaluated the imaging features of 318 HIV-infected
patients, mostly with disseminated mycobacterial disease.
The majority of HIV-infected patients (74%) diagnosed
with TB had intrathoracic adenopathy on chest CT scan
compared with 50% of the patients with NTM infection.
The data did not demonstrate statistically significant dif-
ference in our patients, probably because we evaluated
only the chest X-rays in contrast to CT scan, which has a
higher sensitivity for the detection of intrathoracic aden-
opathy.
Table 3: Abdominal imaging by ultrasound or abdominal CT in HIV-infected patients with disseminated mycobacterial disease
All patients1 (n = 73) MTB (n = 52) NTM (n = 21) P
Adenopathy 45 (61.6) 38 (73.1) 7 (33.3) .003
Hepatomegaly 30 (41.1) 19 (36.5) 11 (52.4) .32
Ascities 25 (34.2) 18 (34.6) 7 (33.3) .86
Splenic hypodensities 20 (27.4) 20 (38.5) 0 (0.0) .002
Hepatosplenomegaly 20 (27.4) 15 (28.8) 5 (23.8) .88
Biliary tract alterations 19 (26.0) 12 (23.1) 7 (33.3) .54
Splenomegaly 18 (24.7) 13 (25.0) 5 (23.8) .84
Liver echotexture alteration 13 (17.8) 7 (13.5) 6 (28.6) .86
Liver hypodensities 8 (11.0) 5 (9.6) 3 (14.3) .74
Pancreatic lesions 3 (4.1) 3 (5.8) 0 (0.0) .63
Intestinal abnormalities 2 (2.7) 2 (3.8) 0 (0.0) .90
Abdominal Abscess 1 (1.4) 1 (1.9) 0 (0.0) .63
Note. Data are no. (%) of patients, unless otherwise indicated. MTB, Mycobacterium tuberculosis; NTM, non-tuberculous mycobacteria.
1 Patients diagnosed with tuberculosis, and non-tuberculous mycobacteria infection.BMC Infectious Diseases 2008, 8:24 http://www.biomedcentral.com/1471-2334/8/24
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Miliary infiltrate was highly associated with diagnosis of
TB. Considering that our HIV-infected patients with NTM
did not present miliary pattern on chest X-ray. Hsieh et al
[37] have found that none of their HIV-infected patients
with MAC presented miliary pattern on chest X-ray. How-
ever, three HIV-infected patients with TB presented with
miliary infiltrate on chest x-ray.
In patients with AIDS, atypical radiographic presentation
of TB in severe immunossuppressed patients seems to
occur frequently, and an interstitial diffuse infiltrate is one
of the most common radiographic abnormality [37], as
described in our patients. Significant pulmonary involve-
ment has not been seen commonly in disseminated MAC
infection [38], and a miliary pattern on X-ray is rarely seen
in these patients [39-42]. It has been mostly reported in
patients with infection by non-tuberculous mycobacteria
other than MAC such as patients with Mycobacterium
xenopi infection [43]. However, consolidations or nodular
infiltrates, interstitial infiltrate, pulmonary mass and cav-
itation have been occasionally reported in HIV-infected
patients with MAC infection [42]. In patients with AIDS
and disseminated mycobacterial infection, the presence of
pulmonary disease and miliary changes on X-ray strongly
suggests the diagnosis of TB.
We have found that pleural effusion was associated with
the diagnosis of TB. In contrast to disseminated MAC dis-
ease, pleural effusions have been frequently described in
patients with disseminated TB. In fact, Hsieh et al, found
no patient with MAC and pleural effusion in their study
[37].
Infections due to MAC are related to more immunossu-
pressed states [44,45]. Whereas MTB infections can affect
patients with higher levels of CD4 counts, and is associ-
ated with a greater inflammatory response and granuloma
formation. In our study, HIV-infected patients with dis-
seminated TB had a higher median CD4 lymphocyte
count compared with patients with disseminate NTM.
However when we controlled our results for the lowest
CD4 count strata (CD4 < 50 cels/mm3), all the imaging
differences associated with the diagnosis of TB remained
statistically significant. Some have advocated that the
manifestations of TB in abdomen are related to the immu-
nologic state of the patient [34,35], our data suggest that
even in the lowest strata of CD4 counts, patients with TB
still seem to have more exuberant disease presentation
with abdominal adenopathy and granuloma formation
than NTM disease.
Of interest, the sensitivity of acid-fast smears for the diag-
nosing disseminated disease was low in our patients with
disseminated NTM and tuberculosis mycobacteria. Smith
et al. have shown that positive acid-fast smears were fre-
quently found in patients with disseminated tuberculosis
disease and HIV (96%), and there was no difference
related to HIV-status or level of immunossupression to
the yield of acid-fast sputum smears [46]. Samb et al. eval-
uated factors associated with negative sputum smears in
patients with disseminated TB and pulmonary involve-
ment: absence of cavitation, lack of cough, HIV seroposi-
tivity, CD4 count above 200 cels/mm3, and age over 40
years was associated with smear negativity [47]. In dis-
seminated MAC infection, the sensitivity of acid-fast
smears and cultures from the respiratory tract is character-
istically low [48]. Besides the low sensitivity for diagnos-
ing TB and MAC in HIV-infected patients, the specificity of
the acid-fast smear for the diagnosis of TB in our study was
83%, compared to patients with NTM disease.
Conclusion
In summary, miliary pulmonary pattern, pleural effusion,
abdominal adenopathy, and splenic hypoechoic nodules
were imaging findings associated with the diagnosis of
disseminated  tuberculosis  in HIV-infected patients.
Although the retrospective source of data, our results
emphasize the importance of imaging studies as valuable
tool to help differentiate MTB and NTM disseminated
infections in HIV-infected patients, considering the simi-
lar clinical presentation of both diseases. Recognition of
these imaging features can lead to a tentative diagnosis so
that appropriate therapy can be instituted before the
results of mycobacterial cultures become available.
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